Over the last 20 years there have been reports of a form of chronic kidney disease of unknown cause (CKDu) affecting rural communities in the North Central Province of Sri Lanka. Valid prevalence estimates, using a standardised methodology, are needed to assess the burden of disease, assess secular trends, and perform international comparisons. We conducted a cross-sectional representative population survey in five study areas with different expected prevalences of CKDu. We used a proxy definition of CKDu involving a single measure of impaired kidney function (eGFR< 60 mL/min/1.7m2, using the CKD-Epi formula) in the absence of hypertension, diabetes or heavy proteinuria. A total of 4803 participants (88.7%) took part in the study and 202 (6.0%; 95% CI 5.2–6.8) had a low eGFR in the absence of hypertension, diabetes and heavy proteinuria and hence met the criteria for proxy CKDu. The proportion of males (11.2%; 95% CI 9.2–13.1) were triple than the females (3.7%; 95% CI 2.9–4.5). Advancing age and history of CKD among parents or siblings were risk factors for low GFR among both males and females while smoking was found to be a risk factor among males. These data, collected using a standardised methodology demonstrate a high prevalence of impaired kidney function, not due to known causes of kidney disease, in the selected study areas of the Anuradhapura district of Sri Lanka. The aetiology of CKDu in Sri Lanka remains unclear and there is a need for longitudinal studies to describe the natural history and to better characterise risk factors for the decline in kidney function.
A better understanding of population-level factors related to measles case fatality is needed to estimate measles mortality burden and impact of interventions such as vaccination. This study aimed to develop a conceptual framework of mechanisms associated with measles case fatality ratios (CFRs) and assess the scope of evidence available for related indicators. Using expert consultation, we developed a conceptual framework of mechanisms associated with measles CFR and identified population-level indicators potentially associated with each mechanism. We conducted a literature review by searching PubMed on 31 October 2021 to determine the scope of evidence for the expert-identified indicators. Studies were included if they contained evidence of an association between an indicator and CFR and were excluded if they were from non-human studies or reported non-original data. Included studies were assessed for study quality. Expert consultation identified five mechanisms in a conceptual framework of factors related to measles CFR. We identified 3772 studies for review and found 49 studies showing at least one significant association with CFR for 15 indicators (average household size, educational attainment, first- and second-dose coverage of measles-containing vaccine, human immunodeficiency virus prevalence, level of health care available, stunting prevalence, surrounding conflict, travel time to major city or settlement, travel time to nearest health care facility, under-five mortality rate, underweight prevalence, vitamin A deficiency prevalence, vitamin A treatment, and general malnutrition) and only non-significant associations for five indicators (antibiotic use for measles-related pneumonia, malaria prevalence, percent living in urban settings, pneumococcal conjugate vaccination coverage, vitamin A supplementation). Our study used expert consultation and a literature review to provide additional insights and a summary of the available evidence of these underlying mechanisms and indicators that could inform future measles CFR estimations.
19 April 2018 in Journal of the College of Community Physicians of Sri Lanka
Introduction The Human Papilloma Virus (HPV) infection is known to cause anogenital cancers. Male HPV prevalence and population-attributable risk (PAR)are important to plan future HPV preventive strategies for HPV-driven anogenital cancers in males. Methods A hospital-based case-control study was carried out to determine the etiologic fraction attributed to HPV-driven anal and penile(anogenital) cancers among male patients presenting to tertiary care hospitals in Gampaha district and Apeksha Hospital (cancer specialized), Sri Lanka and to calculate PAR percentage on anogenital SCC among the study population where HPV prevalence was 5.7%. New or already diagnosed patients for anal and penile SCC who reported to selected hospitals from August 2022 to June 2023 were recruited for data and specimen collection. A sample size of 20 cases and 80 controls were selected, with four controls chosen per case from sexually active, clinically normal men aged 20-70 years residing in the Gampaha district. Additional etiological factors that were checked included the presence of sexually transmitted infections, phimosis, anogenital injury, and the use of tobacco, alcohol or illegal drugs. The chi-square test was used at the level p<0.05 significance. Bivariable and logistic regression analyses were used to calculate odds ratios (ORs). Results A significantly associated factor for getting anal and penile SCC was HPV infection (p<0.001; adjusted OR: 27.7; 95% CI: 4.3,177.8).For any HPV genotype & high-risk HPV genotype, prevalence was 55% & 50% among cases and 5% & 2.5% among controls respectively. Assuming prevalence among controls as the population prevalence, the calculated PAR% was 62.2% for any HPV genotype and 33% for the HPV 16 HR genotype. Conclusions Sixty-two per cent of the anal and penile SCCs were attributed to any HPV genotype and one-third of anal and penile SCCs can be prevented by introducing HPV 16 genotype-containing vaccine to male.
14 November 2020 in Journal of the College of Community Physicians of Sri Lanka